Biosimilardevelopment.com

New Cardinal Health Report Examines Shifts In Biosimilars Industry

Web<p>Cardinal Health (NYSE:&nbsp;CAH) released its&nbsp;2023 Biosimilars Report: Tracking market expansion and sustainability amidst a shifting industry, a …

Actived: 3 days ago

URL: https://www.biosimilardevelopment.com/doc/new-cardinal-health-report-examines-shifts-in-biosimilars-industry-0001

Biosimiliars In Hospital Settings What You Need To Know

WebA few months ago, Biosimilar Development published an interview with Dave Picard, VP of biosimilars and injectables for AmerisourceBergen, who shared his …

Category:  Health Go Health

EmpiRx Health Expands Value-Based PBM Leadership By …

Web<p>EmpiRx Health, the leader in clinically-driven, customer-first pharmacy care, today announced that after careful clinical review it has added two Humira …

Category:  Health Go Health

Health Canada’s Unique Approach To Biosimilar Regulation

Web<p>Health Canada recently released its revised guidance document on biosimilar submission requirements. Though the revisions were primarily …

Category:  Health Go Health

RxPreferred Flips The Script On Rising Healthcare Costs With Mark …

Web<p>RxPreferred, a transparent Pharmacy Benefits Administrator has announced with Mark Cuban Cost Plus Drug Company, PBC, (Cost Plus Drugs) that …

Category:  Health Go Health

Biosimilars North America Is Returning To New Jersey This …

WebWhile biosimilars are not new in EMEA and few APAC countries (such as Korea and Japan), commercialization in the US has been extremely slow. Resistance from patients, defence …

Category:  Health Go Health

Evernorth Announces Humira Biosimilar Available At 0 Out Of …

WebBloomfield, CT /PRNewswire/ - In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth …

Category:  Health Go Health

Sandoz Head Of US Regulatory Affairs Explores New FDA …

WebSMi Group has announced that Dr Cindy Cao, Executive Director and Head of US Regulatory Affairs for Biopharmaceuticals at Sandoz has joined the speaker panel for the …

Category:  Health Go Health

Evio Pharmacy Solutions Introduces Biosimilar Strategy To Help …

WebAll five Evio investor Blues plans choose to participate. Denver, CO /PRNewswire/ - Evio Pharmacy Solutions, an independent pharmacy solutions company that works with …

Category:  Health Go Health

More Canadians Have Access To HUMIRA (adalimumab) For The …

Web<p>AbbVie recently announced that HUMIRA (adalimumab) will now be reimbursed in British Columbia, Ontario, New Brunswick, Newfoundland and Labrador, Saskatchewan …

Category:  Health Go Health

FDA Holds Meeting On Application For First Biosimilar For Use …

WebCCFA provides testimony advocating for the needs of the Crohn's disease and ulcerative colitis community. New York, NY /PRNewswire-USNewswire/ - The U.S. Food and Drug …

Category:  Food Go Health

Global And USA Biosimilar Market Latest Updates From Hospira …

WebLeading organizations in the Biosimilars Development sector will meet at Biosimilars & Biobetters USA 2015 in Iselin this November. The global biosimilar and …

Category:  Health Go Health

Sandoz Canada Receives Authorization From Health Canada To …

WebHyrimoz® approved for use in all same indications as reference medicine* including rheumatology, gastroenterology and dermatology. Third Sandoz biosimilar …

Category:  Medicine Go Health

Will Biosimilars Solve The Insulin Cost-Conundrum In The US

WebThis partnership will allow Sandoz to expedite its market entry of competing biosimilars. Under this agreement, Sandoz will market these insulin biosimilars in the …

Category:  Health Go Health

Health Canada Approves Samsung Bioepis And Biogen’s …

WebBYOOVIZ™ becomes the first Lucentis® biosimilar to be approved in Canada following its approval in Europe and the United States in 2021. Incheon and …

Category:  Health Go Health

CVS Health Launches Cordavis

WebWoonsocket, RI /PRNewswire/ - CVS Health® (NYSE: CVS) today announced that it has launched Cordavis, a wholly owned subsidiary that will work …

Category:  Health Go Health

Abbott Broadens Access To Cutting-Edge Biosimilars In Key …

Web<p>Abbott (NYSE: ABT) announced today an agreement with Spain-based global biotech leader mAbxience Holdings S.L. to commercialize several biosimilars …

Category:  Health Go Health

PEI Announces Transition To Cost-Saving Biosimilar Medicines

WebResidents of the province who are enrolled in the PEI Pharmacare program and take certain biologic medicines will need to transition to a biosimilar biologic …

Category:  Medicine Go Health

Sandoz Receives Health Canada Approval For Jubbonti First And …

WebBiosimilar Jubbonti ® approved for all indications of Prolia * reference medicine.; Sandoz continues to expand access for patients in Canada, offering …

Category:  Medicine Go Health

West Coast Employers Eye Biosimilars

WebBy Anna Rose Welch, Editorial & Community Director, Advancing RNA. In recent weeks, I’ve been writing about how nonprofit employer groups around the country …

Category:  Health Go Health

Fresenius Kabi Launches Tyenne<Sup>*</Sup>, The First …

Web<p>Fresenius Kabi, a global health care company that specializes in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for …

Category:  Nutrition,  Medical Go Health

Samsung Bioepis Announces Launch Of ONTRUZANT …

WebONTRUZANT (trastuzumab) is Samsung Bioepis’ first oncology treatment and second product to be launched in Brazil followed by BRENZYS, both in partnership …

Category:  Health Go Health